Fabtech Tech. Stock Price Today (NSE: FABTECH)
Fundamental Score
Fabtech Tech. Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Fabtech Tech. share price today is ₹148.63, down 1.08% on NSE/BSE as of 7 August 2026. Fabtech Tech. (FABTECH) is a Small-cap company in the Healthcare Research, Analytics & Technology sector with a market capitalisation of ₹701.53 (Cr). The 52-week high for FABTECH share price is ₹262.80 and the 52-week low is ₹132.70. At a P/E ratio of 18.95x, FABTECH is currently trading below its industry average P/E of 39.78x. The company has a Return on Equity (ROE) of 12.49% and a debt-to-equity ratio of 0.17.
Fabtech Tech. Share Price Chart — NSE/BSE Historical Performance
Fabtech Tech. share price chart: -5.12% return over the past month. 52-week high ₹262.80, 52-week low ₹132.70.
Fabtech Tech. — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹150.00 | ₹153.00 | ₹148.00 | ₹148.63 | 52.58K (Cr) | |
| ₹152.99 | ₹152.99 | ₹149.50 | ₹150.25 | 29.31K (Cr) | |
| ₹152.77 | ₹154.00 | ₹150.36 | ₹151.88 | 80.58K (Cr) | |
| ₹150.88 | ₹153.00 | ₹149.65 | ₹151.55 | 89.93K (Cr) | |
| ₹151.69 | ₹152.50 | ₹149.00 | ₹149.77 | 66.67K (Cr) | |
| ₹150.08 | ₹153.51 | ₹147.50 | ₹149.46 | 1.34L (Cr) | |
| ₹148.31 | ₹151.50 | ₹147.10 | ₹150.08 | 1.14L (Cr) | |
| ₹147.23 | ₹151.05 | ₹147.23 | ₹149.57 | 69.11K (Cr) | |
| ₹148.30 | ₹153.12 | ₹147.22 | ₹149.07 | 2.01L (Cr) | |
| ₹149.00 | ₹152.99 | ₹145.10 | ₹148.90 | 1.39L (Cr) |
Fabtech Tech. — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹151.69 | ₹154.00 | ₹148.00 | ₹148.63 | -2.02% | |
| ₹156.77 | ₹176.80 | ₹145.10 | ₹149.46 | -4.66% | |
| ₹157.70 | ₹165.00 | ₹141.61 | ₹156.29 | -0.89% | |
| ₹170.00 | ₹176.00 | ₹144.90 | ₹155.38 | -8.60% | |
| ₹143.00 | ₹182.79 | ₹138.28 | ₹168.63 | +17.92% | |
| ₹141.00 | ₹164.80 | ₹132.70 | ₹139.15 | -1.31% | |
| ₹164.00 | ₹172.67 | ₹137.29 | ₹150.04 | -8.51% | |
| ₹196.90 | ₹202.00 | ₹155.16 | ₹162.93 | -17.25% | |
| ₹241.40 | ₹256.95 | ₹195.11 | ₹196.71 | -18.51% | |
| ₹231.79 | ₹258.00 | ₹220.21 | ₹239.67 | +3.40% | |
| ₹192.00 | ₹262.80 | ₹173.28 | ₹230.71 | +20.16% |
AI Research Briefing
Powered by Gemini · 2026-04-17
Life sciences infrastructure play; order execution is everything.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Fabtech Tech's consolidated order book stood at over Rupal Dhiren Haria was appointed as an Independent Director, and the board committees were reconstituted. The company also approved carrying forward IPO proceeds to FY 2026-27.
CORE STORY (THE REAL GAME)
Fabtech is pitching itself as a global life sciences infrastructure play, targeting medicinal sovereignty projects. The real game is riding the wave of increased healthcare spending and the push for local pharmaceutical manufacturing, especially in emerging markets.
- Strong order book provides revenue visibility
- Expansion into emerging markets like Africa
- Focus on high-growth life sciences sector
- New order wins
- Successful project execution
- Strategic acquisitions
- Small-cap liquidity risk
- Negative free cash flow
- Revenue recognition issues
FII: 1.91% (Δ None%) | DII: 11.63% (Δ None%) | Promoter: 68.94% (Δ None%) - Institutional holding is relatively low, indicating limited smart money interest.
Tailwind: Increased healthcare spending and focus on local pharmaceutical manufacturing.
Consolidated order book over ₹900 Crore as of March 31, 2026. Secured a $7.05 million (₹63.6 crore) order from West Africa for an Oral Solid Dosage facility.
No: Free Cash Flow 5Y: ₹-4.68 Cr
Focus on executing existing orders and securing new contracts in the life sciences sector. Expect 30% growth for FY27.
Primary Thesis Risk
Failure to execute orders will crater the stock.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Fabtech Tech. Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Fabtech Tech. Fundamental Analysis & Valuation Benchmarking
Educational evaluation of FABTECH across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Attractive Valuation (P/E: 18.95 vs Industry: 39.78)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (46.19%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (17.54%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (27.69% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (35.75% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.17)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (12.18x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (68.94%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Weak Earnings Growth (-74.70% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Negative Free Cash Flow (₹-14.96 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 2.47%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Fabtech Tech. vs Healthcare Research, Analytics & Technology Peers
Peer Comparison -
Compare Fabtech Tech. with 9 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Fabtech Tech.Fabtech Tech....Selected✓ FABTECH • 544558 | 66/100 | ₹148.63₹149 | ₹701.53₹701.53 | 18.95Average 18.9 Average | 12.49%Average 12.49% Average | 13.58%Average 13.58% Average | 0.17Excellent 0.2 Excellent | 35.75%Excellent 35.75% Excellent | 27.69%Excellent 27.69% Excellent | 0.00% |
Syngene International LtdSyngene Interna... SYNGENE • 539268 | 35.4/100 | ₹385.90₹386 | ₹16982.38₹16982.38 | 47.13Average 47.1 Average | 7.71%Poor 7.71% Poor | 9.91%Poor 9.91% Poor | 0.04Excellent 0.0 Excellent | -0.98%Poor -0.98% Poor | 9.45%Good 9.45% Good | 0.30% |
Indegene LtdIndegene Ltd... INDGN • 544172 | 57/100 | ₹515.15₹515 | ₹12302.12₹12302.12 | 29.67Average 29.7 Average | 14.41%Average 14.41% Average | 18.82%Good 18.82% Good | 0.05Excellent 0.1 Excellent | 23.02%Excellent 23.02% Excellent | 29.44%Excellent 29.44% Excellent | 0.39% |
Suven Life Sciences LtdSuven Life Scie... SUVEN • 530239 | 11.4/100 | ₹307.10₹307 | ₹10067.84₹10067.84 | — — | -78.80%Poor -78.80% Poor | -76.92%Poor -76.92% Poor | 0.03Excellent 0.0 Excellent | — — | -12.01%Poor -12.01% Poor | 0.00% |
Vimta Labs LtdVimta Labs Ltd... VIMTALABS • 524394 | 63.6/100 | ₹608.85₹609 | ₹2555.98₹2555.98 | 32.42Average 32.4 Average | 18.87%Good 18.87% Good | 25.23%Excellent 25.23% Excellent | 0.01Excellent 0.0 Excellent | 29.96%Excellent 29.96% Excellent | 14.27%Good 14.27% Good | 0.35% |
Take Solutions LtdTake Solutions ... TAKE • 532890 | 31.2/100 | ₹21.42₹21 | ₹304.13₹304.13 | 71.39Average 71.4 Average | 16.53%Good 16.53% Good | 18.51%Good 18.51% Good | 0.00Excellent 0.0 Excellent | 15.08%Excellent 15.08% Excellent | -41.25%Poor -41.25% Poor | 0.00% |
NOVELIX PHARMACEUTICALS LIMITENOVELIX PHARMAC... NOVELIX • 536565 | 56.9/100 | ₹69.49₹69 | ₹199.32₹199.32 | 77.86Average 77.9 Average | 8.00%Poor 8.00% Poor | 9.98%Poor 9.98% Poor | 0.09Excellent 0.1 Excellent | 22.72%Excellent 22.72% Excellent | 151.69%Excellent 151.69% Excellent | 0.00% |
Bilcare LtdBilcare Ltd... BI • 526853 | 28.9/100 | ₹58.17₹58 | ₹147.94₹147.94 | 26.80Average 26.8 Average | 1.66%Poor 1.66% Poor | 5.56%Poor 5.56% Poor | 3.15Poor 3.1 Poor | 16.32%Excellent 16.32% Excellent | 3.33%Average 3.33% Average | 0.00% |
Adeshwar Meditex LtdAdeshwar Medite... ADESHWAR • 543309 | 24.6/100 | ₹16.30₹16 | ₹24.53₹24.53 | 19.47Average 19.5 Average | 3.35%Poor 3.35% Poor | 5.21%Poor 5.21% Poor | 0.16Excellent 0.2 Excellent | -6.68%Poor -6.68% Poor | -3.19%Poor -3.19% Poor | 0.00% |
Vanta Bioscience LtdVanta Bioscienc... VANTABIO • 540729 | 23.9/100 | ₹24.03₹24 | ₹17.99₹17.99 | 163.55Average 163.6 Average | 0.70%Poor 0.70% Poor | 1.19%Poor 1.19% Poor | 1.80Average 1.8 Average | -24.21%Poor -24.21% Poor | -28.62%Poor -28.62% Poor | 0.00% |
Top Healthcare Research, Analytics & Technology Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Syngene International Ltd share price16982.38 Cr
- Indegene Ltd share price12302.12 Cr
- Suven Life Sciences Ltd share price10067.84 Cr
- Vimta Labs Ltd share price2555.98 Cr
- Take Solutions Ltd share price304.13 Cr
Fabtech Tech. Quarterly Performance
Latest quarterly metrics for FABTECH — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
17.54%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
46.19%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
27.69%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
35.75%
Compounded annual net profit growth over 5 years
Fabtech Tech. Technical Indicators
SMA 50, SMA 200, RSI and volume signals for FABTECH — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
Fabtech Tech. Financial Statements
Annual income statement, balance sheet and cash flow for Fabtech Tech. (FABTECH) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Fabtech Tech.
About FABTECH (Fabtech Tech.)
Fabtech Tech. (FABTECH) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Healthcare Research, Analytics & Techno...logy sector with a current market capitalisation of ₹701.53 (Cr). Fabtech Tech. has delivered a Return on Equity (ROE) of 12.49% and a ROCE of 13.58%. The debt-to-equity ratio stands at 0.17, reflecting the company's capital structure. Investors tracking FABTECH share price can monitor key metrics including P/E ratio, promoter holding of 68.94%, and quarterly earnings growth.
Company Details
FABTECH Share Price: Frequently Asked Questions
What is the current share price of Fabtech Tech.?
Fabtech Tech. (FABTECH) trades at ₹148.63 on NSE and BSE. Market cap ₹701.53 (Cr). Educational data only.
What is the P/E ratio of Fabtech Tech.?
Fabtech Tech. has a P/E of 18.95x vs industry average 39.78x.
What is the Bull Run score for Fabtech Tech.?
Fabtech Tech. has a Bull Run score of 66/100 based on 25+ financial parameters.
Does Fabtech Tech. pay dividends?
Fabtech Tech. has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Fabtech Tech.?
Fabtech Tech. has ROE of 12.49%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Fabtech Tech.?
Fabtech Tech. has debt-to-equity of 0.17.
Is Fabtech Tech. a good investment?
Bull Run gives Fabtech Tech. a score of 66/100. This is not investment advice — consult a SEBI-registered advisor.